Data / Form D filings / Jnana Therapeutics Inc.
Jnana Therapeutics Inc.: Form D filings
Jnana Therapeutics Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on January 26, 2024, reports $107 million sold of a $107 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- One Design Center Place, Suite 19-400, Boston, MA, 02210
- Phone
- (857) 349-9200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1879148
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | Amendment | $106,999,997 | $106,999,997 | 8 | Nov 2, 2022 | sec.gov | |
| Nov 16, 2022 | New notice | $59,999,998 | $59,999,998 | 8 | Nov 2, 2022 | sec.gov | |
| Aug 24, 2021 | New notice | $50,000,000 | $50,000,000 | 14 | Aug 12, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Annie C. Chen | Director | |
| Douglas W. Pagan | Executive Officer | |
| Ronald C. Renaud, Jr. | Director | |
| George W. Vratsanos | Executive Officer | |
| Carlo W. Rizzuto | Director | |
| Terrance G. McGuire | Director | |
| Joanne D. Kotz | Executive Officer, Director | |
| Donald W. Nicholson | Director | |
| Caroline Stark Beer | Executive Officer | |
| Matthew W. Hammond | Director | |
| Brian M. Cali | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Jnana Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.